46,160 ARS
340
0.74%
Last update Dec 16, 4:56 PM -03
Market closed
Day range
45,820
46,620
Previous close
45,820
Open
45,840
Access this stock data via API
Subscribe
Gilead Sciences Inc.
46,160.00
340
0.74%

Overview

Access /time_series data via our API — starting from the Basic plan.

Description

Gilead Sciences Inc. is a biopharmaceutical company renowned for its innovative contributions to the healthcare sector. Specializing in antiviral drugs, Gilead has played a crucial role in the development of treatments for diseases such as HIV/AIDS, hepatitis B and C, and influenza. With a strong emphasis on research and development, the company invests heavily in clinical trials and new formulations to enhance therapeutic outcomes and broaden its drug portfolio. Gilead's strategic mergers and collaborations further bolster its pipeline and market reach. Its products are pivotal not only in improving patient health outcomes but also in addressing public health challenges globally. Headquartered in Foster City, California, Gilead Sciences significantly impacts the biotechnology industry through its advancement of life-saving medicines and its commitment to accessibility and innovation in the pharmaceutical landscape.

About

CEO
Mr. Daniel P. O'Day
Employees
17600
Address
333 Lakeside Drive
Foster City, 94404, CA
United States
Phone
650 574 3000
Website
Instrument type
Depositary receipt
Sector
Healthcare
Industry
Drug Manufacturers - General
Country
Argentina
MIC code
XBUE
Access /profile data via our API — starting from the Grow plan.
Market closed

Exchange is currently closed
Main market opens in 14 hours 55 minutes

20:04
00:00
11:00
17:00
23:59

Trading Hours (Monday - Friday):

Main market
11:00 - 17:00
All times are displayed in the America/Argentina/Buenos_Aires timezone (-03, UTC-03:00).